2376774-73-9

2376774-73-9 structure
2376774-73-9 structure
  • Name: Mcl-1 inhibitor 3
  • Chemical Name: Mcl-1 inhibitor 3
  • CAS Number: 2376774-73-9
  • Molecular Formula: C40H52ClF2N5O7S
  • Molecular Weight: 820.38
  • Catalog: Signaling Pathways Apoptosis Bcl-2 Family
  • Create Date: 2020-04-08 04:41:25
  • Modify Date: 2025-08-25 11:40:27
  • Mcl-1 inhibitor 3 (compound 1) is a highly potent and orally activate macrocyclic Mcl-1 inhibitor (Ki= 0.061 nM; IC50=19 nM in an OPM-2 cell viability assay). Mcl-1 inhibitor 3 shows good pharmacokinetic properties and excellent in vivo efficacy without toxicity[1]. .

Name Mcl-1 inhibitor 3
Description Mcl-1 inhibitor 3 (compound 1) is a highly potent and orally activate macrocyclic Mcl-1 inhibitor (Ki= 0.061 nM; IC50=19 nM in an OPM-2 cell viability assay). Mcl-1 inhibitor 3 shows good pharmacokinetic properties and excellent in vivo efficacy without toxicity[1]. .
Related Catalog
Target

Mcl-1:19 nM (IC50)

Mcl-1:0.061 nM (Ki)

In Vitro Mcl-1 inhibitor 3 shows an IC50 value of 19 nM in an OPM-2 cell viability assay, and a Ki value of 0.061 nM in Mcl-1 HTRF/TR-FRET assay[1].
In Vivo Mcl-1 inhibitor 3 (oral administration; 3, 10, or 30 mg/kg; 6 hours) causes a significant loss of luminescence (∼40%) over vehicle at 30 mg/kg,This effect was observed with unbound drug levels in plasma, the [plasma]u/OPM-2 IC50 values are 0.24, 0.93 and 3.65 μM in 3, 10, 30 mg/kg doses,respectively[1]. Mcl-1 inhibitor 3 (oral administration; 10, 30, or 60 mg/kg; 6 hours) activates Bak by 8-fold at 30 mg/kg and by 14-fold at 60 mg/kg in this OPM-2 Luc assay,this test is based on the detection of activated Bak in nude mice subcutaneously injected with via electrochemiluminescence.[1]. Mcl-1 inhibitor 3 (oral administration; 10, 30, or 60 mg/kg; 30 days) led to a robust dose-dependent tumor growth inhibition at 30 mg/kg (44% TGI) and 34% tumor regression when the animals were dosed at 60 mg/kg.Lastly, no body weight loss is observed in any of the mice in this study efficacy models[1]. Animal Model: Nude miceinjected with HEK293 cells[1] Dosage: 3, 10, or 30 mg/kg Administration: Oral administration Result: Showed a disruption of the Mcl-1/Bak interaction in this in vivo model. Animal Model: Nude mice injected with human OPM-2 multiple myeloma tumor cells[1] Dosage: 10, 30, or 60 mg/kg Administration: Oral administration Result: Exhibited a inhibition of tumor growth without any toxicity.
References

[1]. Rescourio G, Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere.J Med Chem. 2019 Nov 27;62(22):10258-10271.

Molecular Formula C40H52ClF2N5O7S
Molecular Weight 820.38
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.